In the current work, ARG significantly reduced TNF-α and IL-6 levels though inhibiting NF-κB activation in rats, implying that the anti-inflammatory action may be one potential strategy against TAA-induced HE (Develi‐Is et al. 2013). The gene discussed is TNF; the disease is hereditary elliptocytosis.